česky | english | sitemap

Czech Gynaecological and Obstetrical Society | Ministry of Health | Institute of Biostatistics and Analyses, Masaryk University
GlaxoSmithKline     Roche |

Other sources of information
Cervical cytology (in Czech)www.cipek.cz
Cervical cytology
Cancer Screening in the European Unionec.europa.eu
Cancer Screening in the European Union (2017)
[ 10,6 MB]
SVOD - Epidemiology of malignant tumours in the Czech Republicwww.svod.cz
Epidemiology of malignant tumours
in the Czech Republic
NCI Bethesda System
HPV College


News for health professionals

Epidemiology of cervical cancer Screening process References


Year: 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

Invitation to cancer screening is an investment which will pay off in the future
17.12.2013 IBA MU | More information...

The workshop “Cancer Screening Programmes in the Czech Republic and Importance of Personalised Invitation”, held on 5 December 2013 in the Clarion Congress Hotel Prague, was organised by the Institute of Biostatistics and Analyses at the Masaryk University in cooperation with the WHO Office in the Czech Republic, the Kolorektum.cz Initiative, and the Office of Member of the European Parliament Dr. Pavel Poc. The workshop was held under the auspices of Martin Holcát, MD, MBA (Czech Minister of Health), Alena Šteflová, PhD, MPH (Director of the WHO Office in the Czech Republic), and Dr. Pavel Poc (Member of the European Parliament).

New study shows HPV vaccine helping lower HPV infection rates in teen girls
19.6.2013 CDC Press Release | More information...

A new study looking at the prevalence of human papillomavirus (HPV) infections in girls and women before and after the introduction of the HPV vaccine shows a significant reduction in vaccine-type HPV in U.S. teens. The study, published in [the June issue of] The Journal of Infectious Diseases reveals that since the vaccine was introduced in 2006, vaccine-type HPV prevalence decreased 56 percent among female teenagers 14-19 years of age.

HPV associated cancer incidence rates point to needed efforts to increase HPV vaccination coverage
7.1.2013 JNCI Press Release | More information...

Despite the decline in cancer death rates in the U.S., there is an increase in incidence rates for cancers associated with human papillomavirus (HPV) infection and more efforts are needed to increase HPV vaccination coverage levels to prevent the occurrence of these cancers in the future according to a study published in the Journal of the National Cancer Institute.